Insmed Inc. buy Barclays PLC
Start price
01.04.26
/
50%
€143.00
Target price
01.04.27
€204.89
Performance (%)
-24.67%
Price
21.08.26
€106.82
Summary
This prediction is currently active. The prediction for Insmed Inc. disappoints with a performance of -24.67%. This prediction currently runs until 01.04.27. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Insmed Inc. | 0.131% | 0.131% |
| iShares Core DAX® | -1.283% | 4.209% |
| iShares Nasdaq 100 | -3.338% | -1.744% |
| iShares Nikkei 225® | -4.286% | -1.621% |
| iShares S&P 500 | -2.311% | -0.096% |
Comments by Barclays_PLC for this prediction
In the thread Insmed Inc. diskutieren
Insmed (INSM) had its price target raised by Barclays PLC from $231.00 to $237.00. They now have an "overweight" rating on the stock.
Ratings data for INSM provided by MarketBeat